Dr. Phillips touches on a few things to consider how teleheath has changed the delivery of care due to COVID-19. Planning your post-pandemic business strategy, due demand for our specialty, is important. #ACR20 @RheumNow https://t.co/A2dsVy1KSg

Highlighting results from @rheum_covid at #ACR20 Race/ethnicity Associated with Poor Outcomes in #RheumaticDisease Patients with #COVID19 by @MilenaGianfran et al Abstract #0006👉https://t.co/13jsl8BjcH Full paper👉https://t.co/Qeo0dOoIOQ @RheumNow https://t.co/U9cgaYYaOj

• Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Diseas…
• Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Diseas…
• Race/ethnicity Associated with Poor Outcomes in Rheumatic Disease Patients with…

#ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow

Eric Rubin, MD, editor-in-chief @NEJM #ACR20 discusses how New Zealand can have large rugby matches by intervening before infection occurs. #LTF, @RheumNow.

Reminder of the glucocorticoids (GC) paradigm: don’t use them early during viral replication as morbidity and mortality (M&M) can increase with early use! But GCs CAN prevent the late complications that cause M&M when used at the appropriate time point. #ACR20 @RheumNow https://t.co/l2e0J1nANd

The GRA now have >17,000 pts registered! Watch the video link @rheumnow or YouTube: https://t.co/tdp5q7tAPK Please visit the GRA booth @rheum_cat @JYazdanyMD @philipcrobinson @rheum_covid #ACR20 https://t.co/UObvGO3n9Q

• Global Rheumatology Alliance Panel - YouTube
• https://twitter.com/uptoTate/status/1324728442357796864

Where one lives matters! Especially during the #COVID19 "flares" - Geographical variations in risk perception and medication management by rheumatologists vary by #COVID19 case burden in the community. Check our abst#0005 #ACR20 @RheumNow

How would you change csDMARDS and bDMARDS a few days before vaccination - if/when #COVID19 KILLED vaccine comes in (Assuming live vaccine would need strict medication management.) #ACR20 @RheumNow

APS induced by CoViD-19: plenary session 1- another reason we need to break down the silos and involve rheumatologist more! Should we be using anticoagulation in these patients? #ACR20 @RheumNow @OSUWexMed

Data from @rheum_covid global registry: "race & ethnicity associated with poor health outcomes in #rheumaticdisease patients with #COVID19 in US. @MilenaGianfran et al. Important work highlighting health disparities in COVID-19. Abs#0006 #ACR20 @RheumNow https://t.co/4e3gAUJ4q1

Impact of #COVID19 on #rheum patients in Arab region @Nellziade -2163 pts -Negative effects on continuity of care, persistence on chronic meds & #mentalhealth -Recommends better communication & drug availability for pt benefit Abs#0004 #ACR20 @RheumNow https://t.co/EGmBmcleAr

Abs#0012 at #ACR20 shows #rheumatology patients in the US had significant changes to healthcare and access to meds during #COVID19. https://t.co/2x7j47WiZL For patients & clinicians: what do you consider to be the most important impact on rheumatology due to COVID-19? @RheumNow

• Experiences of Patients with Rheumatic Diseases in the US During the Early Mont…

Huge congrats @kmdsilvaMD on your @RheumResearch Scientist Development Award- "Respiratory Complications of #COVID19 in Rheumatic Diseases." Be sure to also join Kristin tomorrow as she presents at the #ACR20 plenary! @MGH_ClinEpi https://t.co/LamvuWTMIW

Delighted to be reporting for @RheumNow at #ACR20! Here, I review the last year in #infection in #rheumaticdiseases (it’s been a busy one!) and highlight just a few of the abstracts on infections (incl #COVID19), #vaccination and #immunogenicity. Enjoy! https://t.co/x1pzyOICAF

• Infection and Rheumatic Diseases: A New Dawn | RheumNow